REATA PHARMACEUTICALS INC's ticker is and the CUSIP is 75615P903. A total of 5 filers reported holding REATA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,972,480 | +1.3% | 88,000 | -9.7% | 0.00% | -25.0% |
| Q1 2023 | $8,855,608 | +649.5% | 97,400 | +213.2% | 0.00% | +300.0% |
| Q4 2022 | $1,181,489 | -87.1% | 31,100 | -91.4% | 0.00% | -75.0% |
| Q3 2022 | $9,140,000 | +1526.3% | 363,700 | +1865.9% | 0.00% | – |
| Q2 2022 | $562,000 | – | 18,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 131,400 | $11,946,888 | 0.04% |
| SIMPLEX TRADING, LLC | 94,300 | $8,573 | 0.01% |
| JANE STREET GROUP, LLC | 97,400 | $8,855,608 | 0.00% |
| JPMORGAN CHASE & CO | 310,000 | $28,185,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |